NCT05239143
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05239143
Title P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Poseida Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Irvine Medical Center Irvine California 92868 United States Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
University of California, San Diego San Diego California 92037 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Cancer Center of Kansas Wichita Kansas 67214 United States Details
University of Maryland Cancer Center Baltimore Maryland 21201 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Montefiore Medical Center The Bronx New York 10467 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field